Introduction
It is commonly acknowledged that smoking tobacco and cigars is a significant cause of a number of oral health conditions. Smoking has a major impact on oral health, contributing to everything from serious oral cancer to periodontal diseases. The detrimental effects of nicotine and other toxic compounds in tobacco go beyond the obvious impairment of the oral cavity; they also include underlying immunological dysfunction. Therefore, it is essential to recognize and prevent tobacco-related oral disorders as soon as possible. Salivary biomarker analysis is one promising diagnostic technique in this area that can provide information about the development and course of many illnesses, especially in smokers.
Why Is Tobacco or Cigar Smoking a Preliminary Factor for Oral Disease?
Cigarette smoking is considered to be one of the principal modifiable risk factors, environmental stressors, or the primary etiologic factor for a range of oral diseases from periodontitis (a persistent inflammation of the gums that erodes the bone and tissues supporting teeth) to even pre-cancer, lip cancer, and oral cancers. From a pathophysiology perspective, cigarette smoking that tends to release nicotine-mediated tricyclic nitrosamine compounds (Tsnas) affects the immune system in humans, by mainly impairing the host defense. This is through the inhibiting of granulocyte functions, of specific white blood cells, that is the neutrophils which produce a characteristic phenomenon called a "respiratory burst " according to current research in oral oncology. As tobacco smoking is held as one of the preliminary carcinogenic materials that would be responsible for creating oxidative stress in oral tissues, it may also have a direct effect on the main supporting tissue of the tooth which is the periodontium, creating periodontal inflammation. In the research studies that highlight the biological impact of stress on periodontal tissues, in the oral cavity, one of the preliminary stress factors is nicotine and its compounds that damage or interfere with oral mucosal tissue immunity. Dental researchers attribute this to the effect of gradual oxygen depletion that occurs with tissue damage, with the "respiratory burst " phenomenon of neutrophils, that is an inflammatory attack or response to the subgingival periodontal pathogens or bacteria.
Further, as oral cancer continues to be on the rise across many developing and even developed countries across the world, ranking eighth in terms of the organ based cancers, it is to be noted that the detrimental impact that has been decoded by medical and dental research concerning tobacco smoking should not be ignored. Public awareness of the same and the importance of dental hygiene, regular dental visits, and diagnostic new age markers like salivary biomarker detection hold crucial roles in shaping public oral health and immunity.
What Is the Concept of Oral Inflammatory Biomarkers?
According to a major 2011 research study and analysis on cigarette smoking by Matthews et al., the rise in oral inflammatory biomarkers would be responsible for causing a range of oral mucosal or lip-based lesions or diseases in the mouth. This would also be because tobacco is one of the major environment-induced stressors to which the oral cavity immune defense is inherently breached.
Dental research shows that the GCF (gingival crevicular fluid) that circulates or seeps within the periodontal pockets of the tooth is primarily one of the sites where you can apply the diagnostic aspect, to detect elevated oral inflammatory biomarkers in smokers. Compared to non-smokers, both in this GCF and in the main salivary content, these inflammatory biomarkers are relevant with respect to the intensity of smoking, the duration of the smoking, and even the extent of the period the individual is exposed to nicotine, from tobacco products, leading to a diagnosis of the elevated inflammatory oral biomarkers.
Why Is the GCF Method Not Practical?
GCF proteins that were profiled by researchers mainly using the latest protein chip technology, indicated the different spectral fingerprints to be significantly varied, in a comparative analysis between smoker and non-smoker control groups. Several spectral peaks have been detected only from the GCF of smokers, meaning that there are over-expressed potentially harmful biomarkers implying oral and systemic diseases, such as matrix metalloproteinases (MMPs) and TIMP-1 (tissue inhibitors of metalloproteinases) - in the case of non-smokers, these biomarkers were significantly reduced or less in quantitative analysis. However, GCF collection is not always an easy or practical method in patients suffering from periodontal diseases, in patients with systemic diseases, or even in oral cancer patients. Salivary sample collection of course is the more easy diagnostic method that dental research and current diagnostic methods rely upon extensively.
What Is the Diagnostic Value of Salivary Samples in Detecting Oral Diseases?
Salivary collection from the affected patients either with periodontal diseases, gingivitis, oral lesions, or even salivary gland tumors - is not only very easy and more practical for sample collection, but it offers the patient more compliance for diagnostics. Saliva, as we know, is the oral buffer and immune defense secreted from the major salivary gland parotid, sub mandibular and sub lingual salivary glands, along with several minor salivary glands in your oral cavity - are mainly composed of water (approximately 98 percent), electrolytes and glycoproteins (two percent) antibacterial enzymes, compounds, etc in a unique formulation that holds immense biological value.
The salivary fluid is attributed to multiple oral functions, be it for rinsing, solubilizing the food substances that you chew and eat, the food and bacterial deposit clearance, the lubrication of oral soft tissues, the formation of food bolus for digestion, the dilution of detritus, for swallowing, for the function of speech, for facilitating mastication, etc to name all of its major functionalities in your mouth. Owing to these multiple components that contribute to the natural oral mucosal coating created by the salivary barrier in your mouth, both the functions of oral digestion and antibacterial defense are carried out effectively in healthy humans. Salivary biomarkers not only have just high sensitivity and specificity but they can be used in the crucial detection of oral cancers, benign as well as malignant salivary gland tumors or lesions, and in addressing serious periodontal diseases, for the dentist or maxillofacial surgeon to develop strategies or solutions in these cases. Similar to the over-expression of salivary biomarkers, be it the matrix metalloproteinases (MMPs), specifically the MMP 8 in diseased saliva and TIMP-1, chemokines, pro-inflammatory cytokine levels, etc - these are measured quantitatively by the oral pathologist in detecting oral diseases.
The location of the disease intracellularly, the size of the inflammatory proteins, and the amount of salivary flow that is affected are the factors that influence the biomarkers that get released in the diseased state.
Conclusion
Salivary biomarker analysis is a useful technique for the early identification and prevention of oral disorders, such as periodontal disease and oral malignancies, especially in cigarette smokers. Clinicians can determine the severity of the disease and create individualized management plans by detecting increased biomarkers including MMPs and TIMP-1. Because saliva collection is easier than with other techniques, this non-invasive diagnostic approach is not only more practical but also improves patient compliance. Patient outcomes can be greatly enhanced by early detection of these biomarkers, which can result in better illness management, slower disease progression, and more successful treatments. Additionally, salivary diagnostics are essential for raising public awareness of health issues, promoting improved oral hygiene habits, and emphasizing the value of routine dental checkups.
